
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.6M | -- | -- | -- | -- |
08/06/2025 | Q2 | $1.5M | -- | -- | -- | -- |
06/24/2025 | Q1 | $1.7M | $1.4M | $0.49 | -$0.48 | $0.97 |
02/11/2025 | Q4 | $1.8M | $1.6M | $0.41 | -- | -- |
11/13/2024 | Q3 | $1.7M | $1.6M | -$0.69 | -- | -- |
08/06/2024 | Q2 | $1.9M | $1.5M | -$0.84 | -- | -- |
06/26/2024 | Q1 | $1.8M | $1.3M | -$0.51 | $0.26 | -$0.77 |
02/14/2024 | Q4 | $1M | $1.3M | $0.02 | -- | -- |
11/13/2023 | Q3 | -- | -- | $0.11 | -- | -- |
08/02/2023 | Q2 | -- | -- | -$0.11 | -- | -- |
06/14/2023 | Q1 | -- | -- | $0.82 | -$0.71 | $1.53 |
02/09/2023 | Q4 | -- | -- | -$0.42 | -- | -- |
11/08/2022 | Q3 | -- | -- | -$0.56 | -$0.74 | $0.18 |
08/08/2022 | Q2 | -- | -- | -$0.71 | -- | -- |
05/20/2022 | Q1 | -- | -- | -$0.60 | $0.45 | -$1.05 |
02/03/2022 | Q4 | -- | -- | -$0.69 | -$0.67 | -$0.02 |
11/03/2021 | Q3 | -- | -- | -$0.10 | -$0.67 | $0.57 |
08/11/2021 | Q2 | -- | -- | -$0.67 | -$0.66 | -$0.01 |
06/15/2021 | Q1 | -- | -- | -$0.62 | -$0.63 | $0.01 |
02/08/2021 | Q4 | -- | -- | -$0.69 | -$0.59 | -$0.11 |
11/16/2020 | Q3 | -- | -- | -$0.94 | -$0.62 | -$0.32 |
08/06/2020 | Q2 | -- | -- | -$0.88 | -$0.61 | -$0.27 |
05/21/2020 | Q1 | -- | -- | -$0.69 | -$0.61 | -$0.08 |
02/19/2020 | Q4 | -- | -- | -$0.52 | -$0.85 | $0.33 |
11/06/2019 | Q3 | -- | -- | -$0.46 | -$0.58 | $0.12 |
08/08/2019 | Q2 | -- | -- | -$0.63 | -$0.60 | -$0.03 |
05/20/2019 | Q1 | -- | -- | -$0.65 | -$0.59 | -$0.07 |
02/08/2019 | Q4 | -- | -- | -$0.57 | -- | -- |
11/07/2018 | Q3 | -- | -- | -$0.81 | -- | -- |
08/10/2018 | Q2 | -- | -- | -$0.85 | -- | -- |
06/05/2018 | Q1 | -- | -- | -$0.61 | -- | -- |
02/06/2018 | Q4 | -- | -- | -$0.01 | -- | -- |
11/07/2017 | Q3 | -- | -- | -$0.57 | -- | -- |
08/08/2017 | Q2 | -- | -- | -$0.55 | -- | -- |
06/06/2017 | Q1 | -- | -- | -$0.97 | -- | -- |
02/07/2017 | Q4 | -- | -- | -$0.51 | -- | -- |
11/03/2016 | Q3 | -- | -- | -$0.54 | -- | -- |
08/09/2016 | Q2 | -- | -- | -$0.70 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.47 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.36 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.38 | -- | -- |
Anterix reported $1.4M worth of top line sales in its most recent quarter.
Anterix announced earnings per share of $0.49 which represents a beat of analyst forecast a -$0.48 per share.
Anterix reported -- that represents -- per share over the last quarter.
Anterix's earnings are forecast to decrease from -$0.61 per share to -$1.58 per share next year representing a decrease of -222.45%.
Anterix's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.